Cingulate Stock Investor Sentiment

CING Stock  USD 4.36  0.16  3.81%   
Roughly 56% of all Cingulate's stockholders are looking to take a long position. The analysis of the overall investor sentiment regarding Cingulate suggests that some traders are interested. The current market sentiment, together with Cingulate's historical and current headlines, can help investors time the market. In addition, many technical investors use Cingulate stock news signals to limit their universe of possible portfolio assets.
  

Cingulate Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Cingulate can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at globenewswire.com         
Cingulate Announces Pricing of 4.0 Million Public Offering
Macroaxis News: globenewswire.com
over a year ago at finance.yahoo.com         
Cingulate Announces Pricing of 4.0 Million Public Offering
Yahoo News
over a year ago at benzinga.com         
Cingulate Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 ...
benzinga news
over a year ago at globenewswire.com         
Cingulate Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 ...
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Werth Family Investment Associates Converts 5.8 Million of Debt into Cingulate Equity at a Premium -...
Google News at Macroaxis
over a year ago at benzinga.com         
Werth Family Investment Associates Converts 5.8 Million of Debt into Cingulate Equity at a Premium
benzinga news
over a year ago at globenewswire.com         
Werth Family Investment Associates Converts 5.8 Million of Debt into Cingulate Equity at a Premium
Macroaxis News: globenewswire.com
over a year ago at finance.yahoo.com         
Werth Family Investment Associates Converts 5.8 Million of Debt into Cingulate Equity at a Premium
Yahoo News
over a year ago at benzinga.com         
Why Mitek Systems Shares Are Trading Higher By 15 Here Are 20 Stocks Moving Premarket
benzinga news
over a year ago at finance.yahoo.com         
Cingulate Announces Presentation of Full Trial Results from Phase 3 Adult Efficacy and Safety Trial ...
Yahoo News
over a year ago at news.google.com         
Cingulate has 300,000 in cash as it works to develop ADHD drug ... - The Business Journals
Google News at Macroaxis
over a year ago at benzinga.com         
Cingulate Director Makes 1.00M Stock Purchase
benzinga news
over a year ago at seekingalpha.com         
Cingulate GAAP EPS of -0.57
seekingalpha News
over a year ago at thelincolnianonline.com         
Cingulate exotic insider transaction detected
news
over a year ago at finance.yahoo.com         
Cingulate Inc. Reports Second Quarter 2023 Financial Resultsand Provides Clinical and Business Updat...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Cingulate that are available to investors today. That information is available publicly through Cingulate media outlets and privately through word of mouth or via Cingulate internal channels. However, regardless of the origin, that massive amount of Cingulate data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cingulate news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cingulate relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cingulate's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cingulate alpha.

Cingulate Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
09/12/2024
2
Acquisition by Brams Matthew of 1000 shares of Cingulate at 5.04 subject to Rule 16b-3
09/30/2024
3
Acquisition by Werth Peter J. of 74500 shares of Cingulate at 1.5198 subject to Rule 16b-3
10/04/2024
4
Acquisition by Schaffer Shane J. of 13267 shares of Cingulate at 1.01 subject to Rule 16b-3
10/11/2024
5
Cingulate Reports Third Quarter 2024 Financial ResultsReflecting 19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
11/07/2024
6
Acquisition by Lawrence Bryan Jay of 5000 shares of Cingulate at 1.18 subject to Rule 16b-3
11/25/2024

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency